Reveal LINQ vs Myocardial Strain
AI Verdict
Choose Reveal LINQ if…
Choose Reveal LINQ if your patient presents with infrequent, unexplained symptoms such as syncope, palpitations, or suspected cryptogenic stroke, where a long-term, continuous ECG monitoring solution is necessary for accurate diagnosis. This implantable cardiac monitor provides up to three years of continuous heart rhythm data, leveraging AI to precisely detect arrhythmias that might otherwise be missed by shorter-term monitoring methods.
View Reveal LINQ →Choose Myocardial Strain if…
Choose Myocardial Strain analysis from Circle CVI's cvi42 platform if you require a comprehensive, AI-powered assessment of cardiac function from Cardiovascular Magnetic Resonance (CMR) or Cardiac Computed Tomography (CCT) images. This tool is ideal for early detection of myocardial dysfunction, quantifying global and regional strain to provide detailed insights into heart muscle health and aid in monitoring disease progression.
View Myocardial Strain →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Reveal LINQ | Myocardial Strain |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | The Reveal LINQ ICM is an implantable device placed just beneath the skin in the upper left side of the chest through a small incision. The system includes a MyCareLink™ Monitor, a bedside unit that collects data from the ICM and sends it to the doctor. The Reveal LINQ Mobile Manager app, used by healthcare professionals, is downloaded to an iPad or Android tablet and paired via Bluetooth to a Medtronic patient connector, which communicates with the ICMs. | On-premise (server-client architecture, integrates with hospital PACS) |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Reveal LINQTool A (Reveal LINQ) offers a minimally invasive insertion procedure and a mobile app for clinicians to manage the device, simplifying the overall experience for both patients and healthcare providers. The patient monitor also facilitates easy data transmission, contributing to a streamlined workflow for long-term monitoring.
Clinical Value
TieBoth tools offer significant, yet distinct, clinical value. Tool A provides continuous, long-term ECG monitoring with AI algorithms to accurately detect cardiac arrhythmias and reduce false alerts, which is crucial for conditions like cryptogenic stroke and unexplained syncope. Tool B offers AI-powered myocardial strain analysis from imaging, enabling early detection of myocardial dysfunction and comprehensive assessment of cardiac function.
Pricing & Value
TieNeither tool provides publicly disclosed pricing information, requiring direct contact with the vendor for details. Without transparent pricing, it is impossible to conduct a head-to-head comparison of their cost-effectiveness. Both tools offer substantial clinical benefits, but their value for money cannot be definitively assessed.
Enterprise Readiness
Reveal LINQTool A is a product of Medtronic, a global leader in medical technology, which implies robust enterprise infrastructure, extensive regulatory compliance (FDA cleared, HIPAA compliant), and established support networks. While Tool B integrates well with hospital PACS and is FDA cleared, Medtronic's sheer scale and global presence provide a stronger foundation for enterprise deployment and long-term reliability.
Innovation
Reveal LINQTool A stands out with its 'world's smallest insertable cardiac monitor' design, combined with AccuRhythmu2122 AI algorithms that significantly reduce false alerts in arrhythmia detection. This blend of miniaturization and AI-driven accuracy for long-term, continuous monitoring represents a more disruptive innovation in the delivery of cardiac diagnostics.
Support & Docs
Reveal LINQAs a product from Medtronic, a major medical device company, Tool A benefits from an extensive global support network, comprehensive training programs, and detailed documentation. While Circle Cardiovascular Imaging also offers support and documentation, Medtronic's established infrastructure and resources likely provide a more robust and readily available support ecosystem.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Reveal LINQ | Myocardial Strain |
|---|---|---|
| Name | Reveal LINQ | Myocardial Strain |
| Description | Medtronic Reveal LINQ is a tiny, implantable cardiac monitor that continuously records ECG for up to three years, utilizing AccuRhythmu2122 AI algorithms to accurately detect and diagnose cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope. | Circle Cardiovascular Imaging's cvi42 platform offers AI-powered myocardial strain analysis for comprehensive assessment of cardiac function from CMR and CCT images, aiding in early detection of myocardial dysfunction. |
| Company | Medtronic | Circle Cardiovascular Imaging |
| Primary Function / Key Feature | Continuous ECG monitoring for up to three years; AccuRhythmu2122 AI algorithms for reduced false alerts (AF and pause); World's smallest insertable cardiac monitor (1.2 mL). | AI-based myocardial deformation analysis; Quantification of longitudinal, circumferential, and radial strain; Supports Cardiovascular Magnetic Resonance (CMR) and Cardiac Computed Tomography (CCT) imaging. |
| Categories | Cardiology AI, Wearables & Remote Monitoring (RPM) | Cardiology AI, Radiology & Imaging AI |
| Specialties | Cardiology, Neurology | Cardiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Reveal LINQ and Myocardial Strain.